Motivated by the preponderance of the mannose receptor in tumorigenic/metastatic TAMs in breast cancer (72–74), here, we set out to deplete CD206+ TAMs in an aggressive TNBC model and study the consequences on the progression and immunosuppressive state of the tumor. This evidence concerns the gene MRC1 and breast cancer.